BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ghosh R, Chakraborty A, Biswas A, Chowdhuri S. Computer aided identification of potential SARS CoV-2 main protease inhibitors from diterpenoids and biflavonoids of Torreya nucifera leaves. J Biomol Struct Dyn 2020;:1-16. [PMID: 33140695 DOI: 10.1080/07391102.2020.1841680] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
Number Citing Articles
1 Tatlı Çankaya Iİ, Devkota HP, Zengin G, Šamec D. Neuroprotective Potential of Biflavone Ginkgetin: A Review. Life (Basel) 2023;13. [PMID: 36836918 DOI: 10.3390/life13020562] [Reference Citation Analysis]
2 Saivish MV, Menezes GDL, Costa VGD, Nebo L, Silva GCDD, Pacca CC, Marques RE, Nogueira ML, Da Silva RA. Structural Insights into Plasticity and Discovery of Flavonoid Allosteric Inhibitors of Flavivirus NS2B–NS3 Protease. Biophysica 2023;3:71-92. [DOI: 10.3390/biophysica3010006] [Reference Citation Analysis]
3 Portilla-martínez A, Ortiz-flores M, Hidalgo I, Gonzalez-ruiz C, Meaney E, Ceballos G, Nájera N. In silico evaluation of flavonoids as potential inhibitors of SARS-CoV-2 main nonstructural proteins (Nsps)—amentoflavone as a multitarget candidate. J Mol Model 2022;28:404. [DOI: 10.1007/s00894-022-05391-6] [Reference Citation Analysis]
4 Hardy E, Fernandez-patron C. Could Endogenous Glucocorticoids Influence SARS-CoV-2 Infectivity? Cells 2022;11:2955. [DOI: 10.3390/cells11192955] [Reference Citation Analysis]
5 Ekaterina S, Victor Gustavo OE, Marianna K, Camila Ferreira M, Juliana Silva N, Marcos Vinicius S, Carlos Rangel R, Reinaldo Barros G, Helena Carla C. In silico phytochemicals analysis as inhibitors of the SARS-COV-2 main protease. Int J Pharm Sci Dev Res 2022;8:038-045. [DOI: 10.17352/ijpsdr.000041] [Reference Citation Analysis]
6 Wang Z, Belecciu T, Eaves J, Reimers M, Bachmann MH, Woldring D. Phytochemical drug discovery for COVID-19 using high-resolution computational docking and machine learning assisted binder prediction. J Biomol Struct Dyn 2022;:1-21. [PMID: 35993534 DOI: 10.1080/07391102.2022.2112976] [Reference Citation Analysis]
7 Hendi AA, Virk P, Awad MA, Elobeid M, Ortashi KMO, Alanazi MM, Alkallas FH, Almoneef MM, Abdou MA. In Silico Studies on Zinc Oxide Based Nanostructured Oil Carriers with Seed Extracts of Nigella sativa and Pimpinella anisum as Potential Inhibitors of 3CL Protease of SARS-CoV-2. Molecules 2022;27:4301. [DOI: 10.3390/molecules27134301] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Farasati Far B, Bokov D, Widjaja G, Setia Budi H, Kamal Abdelbasset W, Javanshir S, Seif F, Pazoki-Toroudi H, Dey SK. Metronidazole, acyclovir and tetrahydrobiopterin may be promising to treat COVID-19 patients, through interaction with interleukin-12. J Biomol Struct Dyn 2022;:1-19. [PMID: 35446232 DOI: 10.1080/07391102.2022.2064917] [Reference Citation Analysis]
9 Ghosh R, Badavath VN, Chowdhuri S, Sen A. Identification of Alkaloids from Terminalia chebula as Potent SARS‐ CoV‐2 Main Protease Inhibitors: An In Silico Perspective. ChemistrySelect 2022;7. [DOI: 10.1002/slct.202200055] [Reference Citation Analysis]
10 Antonopoulou I, Sapountzaki E, Rova U, Christakopoulos P. Inhibition of the main protease of SARS-CoV-2 (Mpro) by repurposing/designing drug-like substances and utilizing nature’s toolbox of bioactive compounds. Computational and Structural Biotechnology Journal 2022. [DOI: 10.1016/j.csbj.2022.03.009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
11 Xiong X, Tang N, Lai X, Zhang J, Wen W, Li X, Li A, Wu Y, Liu Z. Insights Into Amentoflavone: A Natural Multifunctional Biflavonoid. Front Pharmacol 2021;12:768708. [PMID: 35002708 DOI: 10.3389/fphar.2021.768708] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
12 Mishra A, Khan WH, Rathore AS. Synergistic Effects of Natural Compounds Toward Inhibition of SARS-CoV-2 3CL Protease. J Chem Inf Model 2021;61:5708-18. [PMID: 34694807 DOI: 10.1021/acs.jcim.1c00994] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
13 Majdi H, Zar Kalai F, Yeddess W, Saidani M. Phenolic compounds as antiviral agents: An In-Silico investigation against essential proteins of SARS-CoV-2. NRFHH 2022;2:62-78. [DOI: 10.53365/nrfhh/143085] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
14 Saha P, Bose S, Srivastava AK, Chaudhary AA, Lall R, Prasad S. Jeopardy of COVID-19: Rechecking the Perks of Phytotherapeutic Interventions. Molecules 2021;26:6783. [PMID: 34833873 DOI: 10.3390/molecules26226783] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Yan F, Gao F. An overview of potential inhibitors targeting non-structural proteins 3 (PLpro and Mac1) and 5 (3CLpro/Mpro) of SARS-CoV-2. Comput Struct Biotechnol J 2021;19:4868-83. [PMID: 34457214 DOI: 10.1016/j.csbj.2021.08.036] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 10.0] [Reference Citation Analysis]
16 Maya PG, Mahayasih W, Harizal, Herman, Ahmad I. In silico identification of natural products from Centella asiatica as severe acute respiratory syndromecoronavirus 2 main protease inhibitor. J Adv Pharm Technol Res 2021;12:261-6. [PMID: 34345605 DOI: 10.4103/japtr.JAPTR_297_20] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
17 Miroshnychenko KV, Shestopalova AV. Combined use of the hepatitis C drugs and amentoflavone could interfere with binding of the spike glycoprotein of SARS-CoV-2 to ACE2: the results of a molecular simulation study. J Biomol Struct Dyn 2022;40:8672-86. [PMID: 33896392 DOI: 10.1080/07391102.2021.1914168] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
18 Selvaraj J, Sundar P S, Rajan L, Selvaraj D, Palanisamy D, Namboori Pk K, Mohankumar SK. Identification of (2R,3R)-2-(3,4-dihydroxyphenyl)chroman-3-yl-3,4,5-trihydroxy benzoate as multiple inhibitors of SARS-CoV-2 targets; a systematic molecular modelling approach. RSC Adv 2021;11:13051-60. [PMID: 35423848 DOI: 10.1039/d1ra01603b] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]